NASDAQ:ACRV | Profit Breakdown | Acrivon Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2021-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$18.67M-$17.96M
2026-03-31-$19.9M-$19.04M
2025-12-31-$20.12M-$18.99M
2025-09-30-$19.69M-$18.23M
2025-06-30-$22.65M-$21.01M
2025-03-31-$21.66M-$19.68M
2024-12-31-$24.95M-$22.83M
2024-09-30-$25.14M-$22.44M
2024-06-30-$21.44M-$18.8M
2024-03-31-$17.67M-$16.49M
2023-12-31-$21.05M-$19.25M
2023-09-30-$16.14M-$14.47M
2023-06-30-$15.52M-$13.91M
2023-03-31-$14.39M-$12.76M
2022-12-31-$9.95M-$8.93M
2022-09-30-$9.58M-$9.2M
2022-06-30-$5.93M-$5.82M
2022-03-31-$7.21M-$7.22M
2021-12-31-$4.27M-$4.34M
2021-09-30-$2.67M-$2.44M
2021-06-30-$2.55M
2021-03-31-$6.91M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$84.11M-$77.83M-$77.91M
2024-12-31-$89.2M-$80.44M-$80.56M
2023-12-31-$67.1M-$60.39M
2022-12-31-$32.66M-$31.17M
2021-12-31-$16.18M-$16.24M